New data from US centers suggest some overtesting in patients without chest pain, and undertesting in those who do.

These latest data reinforce years of smaller studies, but whether they should change practice is a matter of debate.

The ability to diagnose MI was better with troponin I, but T better predicted mortality. Both tests have strengths, ...